H.I.G. BioHealth Partners
H.I.G. BioHealth Partners invests in a broad range of life science companies across multiple sectors and stages of development.
Business Model:
Revenue: $10M
Employees: 2-10
Rankings
Industries / Tags:
Detailed H.I.G. BioHealth Partners Information
Geographic Data
Address: 1450 Brickell Ave
City: Miami
State: FL
Zip: 33131
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
5,366,840Website Global Rank
1,719Website Monthly Traffic
Twitter Followers
Description
H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Their seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. They invest in companies developing novel products for significant unmet medical needs.
Contact Phone:
+13053792322
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2015 | Orbus Therapeutics | Series A | 32.5M |
| 10/2019 | Zerigo Health | Series A | 0 |
| 8/2012 | NeuWave Medical | Equity | 14M |
| 10/2012 | Cerephex | Series A | 5.9M |
| 5/2020 | Arvelle Therapeutics | Series A | 0 |
| 6/2015 | RxSIGHT | Debt Financing | 17M |
| 3/2018 | On Target Laboratories | Series B | 0 |
| 1/2017 | Intact Vascular | Series B | 0 |
| 3/2017 | VertiFlex | Equity | 45.3M |
| 5/2019 | Intact Vascular | Series D | 0 |
| 5/2015 | NeuWave Medical | Series C | 25.3M |
| 9/2012 | Intact Vascular | Series A | 15.5M |
| 8/2016 | Nutrinia | Series D | 30M |
| 4/2015 | Cardeas Pharma | Series B | 37.5M |
| 5/2018 | Neurana Pharmaceuticals | Series A | 0 |
| 7/2019 | Exagen | Venture Round | 0 |
| 6/2015 | RxSIGHT | Venture Round | 52M |
| 2/2019 | Arvelle Therapeutics | Series A | 0 |
| 4/2018 | Intact Vascular | Series C | 0 |
| 6/2018 | Iconic Therapeutics | Venture Round | 0 |
| 10/2021 | Click Therapeutics | Series B | 0 |
| 5/2015 | Intact Vascular | Series B | 0 |
| 4/2014 | Iconic Therapeutics | Series B | 20M |
| 8/2016 | Iconic Therapeutics | Series C | 10M |
| 4/2014 | ForSight VISION5 | Equity | 15M |
| 4/2014 | ForSight Labs | Series C | 15M |
| 10/2021 | Click Therapeutics | Series B | 0 |
| 5/2020 | Arvelle Therapeutics | Series A | 0 |
| 10/2019 | Zerigo Health | Series A | 0 |
| 7/2019 | Exagen | Venture Round | 0 |
| 5/2019 | Intact Vascular | Series D | 0 |
| 2/2019 | Arvelle Therapeutics | Series A | 0 |
| 6/2018 | Iconic Therapeutics | Venture Round | 0 |
| 5/2018 | Neurana Pharmaceuticals | Series A | 0 |
| 4/2018 | Intact Vascular | Series C | 0 |
| 3/2018 | On Target Laboratories | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
